Peptide InjectionsAI
High evidence

Mazdutide

Peptide therapy: benefits, side effects, cost and protocols

C207H317N45O65

4,476 g/mol / CID 167312357
C207H317N45O65

Mazdutide is a dual GLP-1/glucagon receptor agonist developed by Innovent Biologics for the treatment of obesity and type 2 diabetes. It combines GLP-1-mediated appetite suppression with glucagon-mediated energy expenditure increases.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

FDA status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Strong Evidence

Who Mazdutide is usually considered for

  • Weight management research
  • Dual mechanism
  • Metabolic enhancement

How Mazdutide works

Dual GLP-1 and glucagon receptor agonist that may enhance metabolic effects through complementary pathways.

Key studies

60 papers on PubMed / 40 human trials

  1. 01

    Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes

  2. 02

    Guo L, Zhang B, Xue X et al

    Nature / Phase 3

    Mazdutide superior to dulaglutide for HbA1c reduction and weight loss in Chinese adults with type 2 diabetes.

  3. 03

    Mazdutide superior to dulaglutide for HbA1c reduction and weight loss in Chinese adults with type 2 diabetes

  4. 04

    Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight

  5. 05

    Ji L, Jiang H, Bi Y et al

    N Engl J Med / Phase 3

    Mazdutide 4-6 mg reduced body weight by 11-14% at 48 weeks vs 0.3% with placebo.

  6. 06

    Mazdutide 4-6 mg reduced body weight by 11-14% at 48 weeks vs 0.3% with placebo

  7. 07

    Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial

  8. 08

    Luo Y, Jiang H, Shi B et al

    Contemp Clin Trials / Contemp Clin Trials / Phase 3

    Mazdutide vs semaglutide efficacy and safety in Chinese adults with type 2 diabetes and obesity.

  9. 09

    Mazdutide vs semaglutide efficacy and safety in Chinese adults with type 2 diabetes and obesity

  10. 10

    Mazdutide versus placebo in Chinese adults with type 2 diabetes

Mazdutide compound data

C207H317N45O65
4476 g/mol
167312357 ↗
20-[[(1S)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-2-methyl-propanoyl]amino]-5-oxo-pentanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-carboxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxy-propanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-3-carboxy-propanoyl]amino]-4-carboxy-butanoyl]amino]hexanoyl]amino]hexanoyl]amino]propanoyl]amino]-6-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[2-[[2-[(2S)-2-[[(1S)-2-[(2-amino-2-oxo-ethyl)amino]-1-(hydroxymethyl)-2-oxo-ethyl]carbamoyl]pyrrolidin-1-yl]-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]carbamoyl]-2-methyl-propyl]amino]-1-benzyl-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]amino]-6-oxo-hexyl]amino]-2-oxo-ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]ethoxy]ethylamino]-1-carboxy-4-oxo-butyl]amino]-20-oxo-icosanoic acid

Mazdutide questions

What is MAZDUTIDE?

Mazdutide is an emerging dual agonist peptide targeting both GLP-1 and glucagon receptors, representing the next generation of weight management research compounds.

How does MAZDUTIDE work?

Dual GLP-1 and glucagon receptor agonist that may enhance metabolic effects through complementary pathways.

Is MAZDUTIDE legal to buy?

MAZDUTIDE is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy MAZDUTIDE?

MAZDUTIDE is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does MAZDUTIDE belong to?

MAZDUTIDE is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.

What are the research benefits of MAZDUTIDE?

MAZDUTIDE has been studied for: Weight management research, Dual mechanism, Metabolic enhancement. New dual agonist; emerging weight loss research peptide.

Mazdutide in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering Mazdutide?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz